Suppr超能文献

对蛋白质合成抑制剂依米丁具有抗性的体细胞突变体的分离与初步鉴定。

The isolation and preliminary characterization of somatic cell mutants resistant to the protein synthesis inhibitor-emetine.

作者信息

Gupta R S, Siminovitch L

出版信息

Cell. 1976 Oct;9(2):213-9. doi: 10.1016/0092-8674(76)90112-4.

Abstract

Emetine reversibly inhibits protein synthesis in Chinese hamster ovary (CHO) cells. Stable mutants which are 20-80 fold more resistant to the cytotoxic action of the drug can be isolated in a single step at a frequency of about 2-5 X 10(-7). The frequency of such mutants is increased 30-50 fold by ethyl methane sulphonate mutagenesis, and the spontaneous rate of mutation to emetine resistance as measured by Luria-Delbruck fluctuation analyses is 4.9 X 10(-7) mutations per locus per generation. Protein synthesis in extracts of the mutant cells is resistant to the inhibitory action of the emetine, indicating that the molecular lesion in these cells lies in the protein synthesis machinery.

摘要

依米丁可逆性抑制中国仓鼠卵巢(CHO)细胞中的蛋白质合成。对该药物细胞毒性作用具有20至80倍抗性的稳定突变体可在一步中以约2 - 5×10⁻⁷的频率分离得到。通过甲磺酸乙酯诱变,此类突变体的频率增加30至50倍,并且通过Luria - Delbruck波动分析测定的对依米丁抗性的自发突变率为每代每个基因座4.9×10⁻⁷个突变。突变细胞提取物中的蛋白质合成对依米丁的抑制作用具有抗性,表明这些细胞中的分子损伤存在于蛋白质合成机制中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验